Should rituximab be used to prevent relapse in patients with ANCA-associated vasculitis? (Q42380186)

From Wikidata

Jump to navigation Jump to search

scientific article published on 13 March 2014

edit

Language	Label	Description	Also known as
English	Should rituximab be used to prevent relapse in patients with ANCA-associated vasculitis?	scientific article published on 13 March 2014

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

3974343

retrieved

28 October 2017

editorial

0 references

title

Should rituximab be used to prevent relapse in patients with ANCA-associated vasculitis? (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

3974343

retrieved

28 October 2017

main subject

rituximab

1 reference

based on heuristic

inferred from title

author

Stephen Mcadoo

series ordinal

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

3974343

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24626431%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 June 2020

author name string

Charles D Pusey

series ordinal

2

1 reference

stated in

Europe PubMed Central

PMC publication ID

3974343

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24626431%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 June 2020

publication date

13 March 2014

1 reference

stated in

Europe PubMed Central

PMC publication ID

3974343

retrieved

28 October 2017

published in

Clinical Journal of the American Society of Nephrology

1 reference

stated in

Europe PubMed Central

PMC publication ID

3974343

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24626431%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 June 2020

volume

9

1 reference

stated in

Europe PubMed Central

PMC publication ID

3974343

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24626431%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 June 2020

issue

4

1 reference

stated in

Europe PubMed Central

PMC publication ID

3974343

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24626431%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 June 2020

page(s)

641-644

1 reference

stated in

Europe PubMed Central

PMC publication ID

3974343

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24626431%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 June 2020

cites work

Long-term maintenance therapy using rituximab-induced continuous B-cell depletion in patients with ANCA vasculitis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974343

retrieved

28 May 2018

Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974343

retrieved

28 May 2018

Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974343

retrieved

28 May 2018

The mechanism of anti-CD20-mediated B cell depletion revealed by intravital imaging

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974343

retrieved

28 May 2018

Efficacy and safety of rituximab as maintenance therapy for relapsing granulomatosis with polyangiitis—a case series

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974343

retrieved

28 May 2018

Efficacy of remission-induction regimens for ANCA-associated vasculitis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974343

retrieved

28 May 2018

S3. Rituximab for ANCA-associated vasculitides: the French experience

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974343

retrieved

28 May 2018

Leukocyte and serum S100A8/S100A9 expression reflects disease activity in ANCA-associated vasculitis and glomerulonephritis.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974343

retrieved

28 May 2018

Decreased CD5⁺ B cells in active ANCA vasculitis and relapse after rituximab.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974343

retrieved

28 May 2018

ANCA-stimulated neutrophils release BLyS and promote B cell survival: a clinically relevant cellular process

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974343

retrieved

28 May 2018

Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974343

retrieved

28 May 2018

Prolonged disease-free remission following rituximab and low-dose cyclophosphamide therapy for renal ANCA-associated vasculitis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974343

retrieved

28 May 2018

Rituximab versus cyclophosphamide for ANCA-associated vasculitis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974343

retrieved

28 May 2018

A CD8+ T cell transcription signature predicts prognosis in autoimmune disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974343

retrieved

28 May 2018

EULAR recommendations for the management of primary small and medium vessel vasculitis.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974343

retrieved

28 May 2018

B lymphocyte maturation in Wegener's granulomatosis: a comparative analysis of VH genes from endonasal lesions

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974343

retrieved

28 May 2018

Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in granulomatosis with polyangiitis: results from a single centre.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974343

retrieved

16 August 2018

Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974343

retrieved

16 August 2018

Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974343

retrieved

16 August 2018

Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974343

retrieved

16 August 2018

B cell biomarkers of rituximab responses in systemic lupus erythematosus.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974343

retrieved

16 August 2018

Long-term patient survival in ANCA-associated vasculitis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974343

retrieved

16 August 2018

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974343

retrieved

16 August 2018

Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974343

retrieved

16 August 2018

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3974343

retrieved

16 August 2018

Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24626431

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24626431

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.2215/CJN.01270214

1 reference

stated in

Europe PubMed Central

PMC publication ID

3974343

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24626431%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 June 2020

PMC publication ID

3974343

1 reference

stated in

Europe PubMed Central

PMC publication ID

3974343

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24626431%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 June 2020

PubMed publication ID

24626431

1 reference

stated in

Europe PubMed Central

PMC publication ID

3974343

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24626431%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 June 2020

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42380186&oldid=1570221013"